Funded Tech Companies

AusperBio

AusperBio, operating out of San Mateo, has financial backing from CDH Investments, Genesis and Hankang Capital.

Company Overview

Contact Information

Company Background Information

Overview

AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming HBV treatment for cure and advancing oligonucleotide therapeutics. Leveraging our innovative and proprietary Med-Oligo� ASO platform with effective targeted delivery technologies, we strive to unleash the power of ASO therapeutics to treat a wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases, and to transform patient lives.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

9/22/2025

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Guofeng Cheng

        

Chief Operating Officer

Suyun Xu

        

Chief Scientific Officer

Chris Yang

        

Vice President

Hengxu Wei

        

VP - Bus. Development

Miao Wang

        

VP - Bus. Development

Xuetao Wen

        

VP - R & D

Yang Tian

        

Company Investors

• CDH Investments
• Genesis
• Hankang Capital
• Qiming Venture Partners USA
• Sherpa Capital
• Yuanbio Venture Capital
• Genesis Capital Growth
• InnoPinnacle Fund

Browse more funded tech companies:

Aushon BioSystems | Auspex Pharmaceuticals

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary